Therapeutic control of B cell activation via recruitment of Fcgamma receptor IIb (CD32B) inhibitory function with a novel bispecific antibody scaffold.
Veri MC, Burke S, Huang L, Li H, Gorlatov S, Tuaillon N, Rainey GJ, Ciccarone V, Zhang T, Shah K, Jin L, Ning L, Minor T, Moore PA, Koenig S, Johnson S, Bonvini E.
Veri MC, et al. Among authors: koenig s.
Arthritis Rheum. 2010 Jul;62(7):1933-43. doi: 10.1002/art.27477.
Arthritis Rheum. 2010.
PMID: 20506263
Free article.